Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peanut Oral Immunotherapy (PeanutFlour) in Children
NCT02203799Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2014
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial in peanut allergy, sponsored by Baylor College of Medicine. Primary endpoint: Percentage of Patients Tolerating the 12-month DBPCFC. Started Jul 2014; status: completed.
02
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT02203799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203799.